The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Know Your Labs, Part 2

Know Your Labs, Part 2

April 1, 2009 • By Peter H. Schur, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

This is Part Two of a two-part series. Part One, on SLE and connective tissue disease, appeared in the February issue of The Rheumatologist (p. 1).

You Might Also Like
  • Know Your Labs
  • Do Diet & the Environment Induce RA via ACPA Generation?
  • Antibodies Can Spot RA in the General Population
Explore This Issue
April 2009
Also By This Author
  • Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

Laboratory testing is an essential element in the diagnosis and management of patients with rheumatic disease. This series focuses on a diverse array of serological markers that can provide unique information on the status of the patient’s immune system that is important in clinical evaluation as well as scientific inquiry. These tests help in the diagnosis of a particular disease and, importantly, they may help monitor disease activity. Indeed, immunological testing represents one of the bedrocks of rheumatology and is a distinguishing feature of our specialty.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

While there are many available tests, the approach to serology follows the traditional approach of any laboratory study. Critical in the interpretation of any serological test is determining its sensitivity (i.e., the proportion of patients with the target disorder who have a positive test), specificity (i.e., that proportion of patients who are free of the target disorder and have negative or normal test results), and positive and negative predictive values. The predictive values calculate the likelihood that disease is present or absent based on test results using the test’s sensitivity, specificity, and the probability of disease before the test is performed (pretest probability). This review will cover tests for rheumatoid arthritis (RA).

Rheumatoid Factors

Rheumatoid factors (RFs) are antibodies directed against the Fc portion of immunoglobulin G (IgG). The RF, as currently measured in clinical practice, is an IgM RF, although other immunoglobulin types, including IgG and IgA, have been described.1,2 ELISA or nephelometry generally detects the presence of RF; latex agglutination (a test fraught with technical problems) is still sometimes used. Testing for RF is primarily used for the diagnosis of RA; however, RF may also be present in other rheumatic diseases and chronic infections.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Patients may have detectable serum RF in a variety of rheumatic disorders, many of which share similar features, such as symmetric polyarthritis and constitutional symptoms. These include idiopathic juvenile idiopathic arthritis, palindromic rheumatism, and Sjögren’s syndrome (see Table 1, p. 19).1,2

Nonrheumatic disorders characterized by chronic antigenic stimulation (especially with circulating immune complexes or polyclonal B lymphocyte activation) commonly induce RF production (see Table 1, below right). Included in this group are indolent or chronic infection, as with subacute bacterial endocarditis or hepatitis B or C virus infection, and inflammatory or fibrosing pulmonary disorders, such as sarcoidosis, malignancy, and primary biliary cirrhosis. Rheumatoid factors have been found in up to 5% of young, healthy individuals. The reported incidence may be higher in elderly subjects without rheumatic disease, ranging from 3% to 25%.

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Diagnosis, Rheumatoid arthritis, TestingIssue: April 2009

You Might Also Like:
  • Know Your Labs
  • Do Diet & the Environment Induce RA via ACPA Generation?
  • Antibodies Can Spot RA in the General Population
  • Chance Discovery May Provide RA Diagnostic

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.